NNCSF

Healthcare Medical Instruments & Supplies

Nanosonics Limited

$2.04

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

609.11M

Avg Volume

689

P/E (TTM)

50.90

EPS

$0.04

52W High

$3.06

52W Low

$1.93

Div. Yield

0.0%

Valuation

P/B Ratio

3.95

P/S Ratio

2.99

EV/EBITDA

21.55

EV/Revenue

2.34

Margins

Gross Margin 76.9%

Operating Margin 7.7%

Net Margin 8.7%

EBITDA Margin 10.8%

Growth & Returns

Revenue Growth (YoY)

(3.2%)

Earnings Growth (YoY)

(24.9%)

Earnings Growth (QoQ)

(25.0%)

Return on Equity

8.3%

Return on Assets

3.7%

Liquidity & Leverage

Current Ratio

5.56

Quick Ratio

4.67

Debt / Equity

0.11

Total Cash

155.22M

Total Debt

23.13M

About

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.